178 related articles for article (PubMed ID: 11303149)
21. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
22. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
Hübel K; Engert A
Onkologie; 2003 Feb; 26(1):73-9. PubMed ID: 12624522
[TBL] [Abstract][Full Text] [Related]
24. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
25. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy.
Ikemoto J; Yoshihara S; Fujioka T; Ohtsuka Y; Fujita N; Kokubunji A; Okamoto N; Ono J; Taniguchi K; Kaida K; Ikegame K; Okada M; Tanizawa T; Ogawa H; Kai S
Transfusion; 2012 Dec; 52(12):2646-52. PubMed ID: 22519863
[TBL] [Abstract][Full Text] [Related]
26. Hypercoagulable state following transfusions of granulocytes obtained from granulocyte colony-stimulating factor-stimulated donors.
Mizuno S; Okamura T; Iwasaki H; Ohno Y; Akashi K; Inaba S; Niho Y
Int J Hematol; 2000 Jul; 72(1):115-7. PubMed ID: 10979222
[No Abstract] [Full Text] [Related]
27. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.
Ofran Y; Avivi I; Oliven A; Oren I; Zuckerman T; Bonstein L; Rowe JM; Dann EJ
Vox Sang; 2007 Nov; 93(4):363-9. PubMed ID: 18070282
[TBL] [Abstract][Full Text] [Related]
28. [Granulocyte transfusion – when and how should it be used?].
Berlin G; Cherif H; Knutson F; Mattsson J; Axdorph Nygell U
Lakartidningen; 2018 Mar; 115():. PubMed ID: 29558012
[TBL] [Abstract][Full Text] [Related]
29. Eighteen years experience of granulocyte donations-acceptable donor safety?
Axdorph Nygell U; Sollén-Nilsson A; Lundahl J
J Clin Apher; 2015 Oct; 30(5):265-72. PubMed ID: 25546372
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
Heuft HG; Goudeva L; Blasczyk R
Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
[TBL] [Abstract][Full Text] [Related]
31. An examination of ethical issues raised in the pretreatment of normal volunteer granulocyte donors with granulocyte colony-stimulating factor.
Volk EE; Domen RE; Smith ML
Arch Pathol Lab Med; 1999 Jun; 123(6):508-13. PubMed ID: 10383803
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes.
Drewniak A; Boelens JJ; Vrielink H; Tool AT; Bruin MC; van den Heuvel-Eibrink M; Ball L; van de Wetering MD; Roos D; Kuijpers TW
Haematologica; 2008 Jul; 93(7):1058-67. PubMed ID: 18508794
[TBL] [Abstract][Full Text] [Related]
33. Life-threatening paroxysmal supraventricular tachycardia developed during granulocyte transfusion therapy for neutropenia-related infection.
Lee JJ; Chung IJ; Ahn YK; Park MR; Shin DH; Cho JG; Kim HJ
Leukemia; 2000 Jul; 14(7):1324-5. PubMed ID: 10914563
[No Abstract] [Full Text] [Related]
34. Toll-like receptor-induced reactivity and strongly potentiated IL-8 production in granulocytes mobilized for transfusion purposes.
Drewniak A; Tool AT; Geissler J; van Bruggen R; van den Berg TK; Kuijpers TW
Blood; 2010 Jun; 115(22):4588-96. PubMed ID: 20354173
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis.
Weingarten C; Pliez S; Tschiedel E; Grasemann C; Kreissig C; Schündeln MM
Eur J Pediatr; 2016 Oct; 175(10):1361-9. PubMed ID: 27631588
[TBL] [Abstract][Full Text] [Related]
36. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor.
Caspar CB; Seger RA; Burger J; Gmür J
Blood; 1993 Jun; 81(11):2866-71. PubMed ID: 7684619
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions.
Price TH
Curr Opin Hematol; 1998 Nov; 5(6):391-5. PubMed ID: 9814645
[TBL] [Abstract][Full Text] [Related]
38. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
Heuft HG; Goudeva L; Pulver N; Grigull L; Schwella N; Blasczyk R
Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
[TBL] [Abstract][Full Text] [Related]
40. Storage of G-CSF-mobilized granulocyte concentrates.
Lightfoot T; Leitman SF; Stroncek DF
Transfusion; 2000 Sep; 40(9):1104-10. PubMed ID: 10988314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
